MacDonald, DI;
Sikandar, S;
Weiss, J;
Pyrski, M;
Luiz, AP;
Millet, Q;
Emery, EC;
... Wood, JN; + view all
(2021)
A central mechanism of analgesia in mice and humans lacking the sodium channel NaV1.7.
Neuron
10.1016/j.neuron.2021.03.012.
(In press).
Preview |
Text
1-s2.0-S0896627321001604-main.pdf - Published Version Download (4MB) | Preview |
Abstract
Deletion of SCN9A encoding the voltage-gated sodium channel NaV1.7 in humans leads to profound pain insensitivity and anosmia. Conditional deletion of NaV1.7 in sensory neurons of mice also abolishes pain, suggesting that the locus of analgesia is the nociceptor. Here we demonstrate, using in vivo calcium imaging and extracellular recording, that NaV1.7 knockout mice have essentially normal nociceptor activity. However, synaptic transmission from nociceptor central terminals in the spinal cord is greatly reduced by an opioid-dependent mechanism. Analgesia is also reversed substantially by central but not peripheral application of opioid antagonists. In contrast, the lack of neurotransmitter release from olfactory sensory neurons is opioid independent. Male and female humans with NaV1.7-null mutations show naloxone-reversible analgesia. Thus, inhibition of neurotransmitter release is the principal mechanism of anosmia and analgesia in mouse and human Nav1.7-null mutants.
Loading...
Loading...Loading...Loading...Archive Staff Only
 |
View Item |
